The case of Amgen v. Sandoz signals that preliminary injunctions will play major role in future patent disputes
Mindy Ehrenfried
Advertisement
Articles by Mindy Ehrenfried
Advertisement
Latest Updated Articles
Biosimilar Litigation: Lessons So FarPublished: August 5th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
